Increased S100B Serum Levels in Dilated Cardiomyopathy Patients

Journal of Cardiac Failure

Volumn 13, Issue 10, 2007, Pages 850-854

  Mazzini, Guilherme S ^a   Schaf, Débora V ^a   Vinadé, Elsa R ^a   Horowitz, Estela ^b   Bruch, Ricardo S ^b   Brunm, Liz M B P ^b   Gonçalves, Carlos A ^a   Bacal, Fernando ^c   Souza, Diogo O ^a   Portela, Luis V C ^a   Bordignon, Solange ^b  

^a Instituto de Ciencias Biologicas e da Saude Pontifical Catholic University of Minas Gerais   (Brazil)

^b INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Heart failure; natriuretic peptides; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; PROTEIN S100B;

ADULT; ARTICLE; CLINICAL EVALUATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SEX;

BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE GROWTH FACTORS; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN PRECURSORS; S100 PROTEINS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME;

EID: 36849068438     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.07.009     Document Type: Article

References (22)

1. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93 (1996) 841-842
2. Cohn J.N., Bristow M.R., Chien K.R., Colucci W.S., Frazier O.H., Leinwand L.A., et al. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 95 (1997) 766-770
3. Matsumori A., Furukawa Y., Hasegawa K., Sato Y., Nakagawa H., Morikawa Y., et al. Epidemiologic and clinical characteristics of cardiomyopathies in Japan: results from nationwide surveys. Circ J 66 (2002) 323-336
4. Gardner R.S., Ozalp F., Murday A.J., Robb S.D., and McDonagh T.A. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24 (2003) 1735-1743
5. Nakagawa O., Ogawa Y., Itoh H., Suga S., Komatsu Y., Kishimoto I., et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 96 (1995) 1280-1287
6. O'Donoghue M., Chen A., Baggish A.L., Anwaruddin S., Krauser D.G., Tung R., et al. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Card Fail 11 (2005) S9-S14
7. Januzzi J.L., van Kimmenade R., Lainchbury J., Bayes-Genis A., Ordonez-Llanos J., Santalo-Bel M., et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients The International Collaborative of NT-proBNP Study. Eur Heart J 27 (2006) 330-337
8. Bottiger B.W., Mobes S., Glatzer R., Bauer H., Gries A., Bartsch P., et al. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 103 (2001) 2694-2698
9. HerrMann M., Vos P., Wunderlich M.T., de Bruijn C.H., and Lamers K.J. Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 31 (2000) 2670-2677
10. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33 (2001) 637-668
11. Missler U., Orlowski N., Notzold A., Dibbelt L., Steinmeier E., and WiesMann M. Early elevation of S-100B protein in blood after cardiac surgery is not a predictor of ischemic cerebral injury. Clin Chim Acta 321 (2002) 29-33
12. Snyder-Ramos S.A., Gruhlke T., Bauer H., Bauer M., Luntz A.P., Motsch J., et al. Cerebral and extracerebral release of protein S100B in cardiac surgical patients. Anaesthesia 59 (2004) 344-349
13. Mazzini G.S., Schaf D.V., Oliveira A.R., Goncalves C.A., Bello-Klein A., Bordignon S., et al. The ischemic rat heart releases S100B. Life Sci 77 (2005) 882-889
14. Tsoporis J.N., Marks A., Haddad A., Dawood F., Liu P.P., and Parker T.G. S100B expression modulates left ventricular remodeling after myocardial infarction in mice. Circulation 111 (2005) 598-606
15. Tsoporis J.N., Marks A., Kahn H.J., Butany J.W., Liu P.P., O'Hanlon D., et al. Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice. J Clin Invest 102 (1998) 1609-1616
16. Tsoporis J.N., Marks A., Kahn H.J., Butany J.W., Liu P.P., O'Hanlon D., et al. S100b inhibits a1-adrenergic induction of the hypertrophic phenotype in cardiac myocytes. J Biol Chem 272 (1997) 31915-31921
17. Rakar S., Sinagra G., Di Lenarda A., Poletti A., Bussani R., Silvestri F., et al. Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group. Eur Heart J 18 (1997) 117-123
18. Rihal C.S., Nishimura R.A., Hatle L.K., Bailey K.R., and Tajik A.J. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation 90 (1994) 2772-2779
19. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 79 (1999) 215-262
20. Manolio T.A., Baughman K.L., Rodeheffer R., Pearson T.A., Bristow J.D., Michels V.V., et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am J Cardiol 69 (1992) 1458-1466
21. Portela L.V., Tort A.B., Schaf D.V., Ribeiro L., Nora D.B., Walz R., et al. The serum S100B concentration is age dependent. Clin Chem 48 (2002) 950-952
22. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)